| Typicality: | 0.628 |
| Saliency: | 0.506 |
| in patients with relapsed or refractory | 4 | other |
| highly | 3 | degree |
| against leukemic cells | 3 | transitive-object |
| combination → be → active | 31 |
| combination → be → engaged | 4 |
| negative | neutral | positive |
| 0.104 | 0.500 | 0.396 |
| Raw frequency | 35 |
| Normalized frequency | 0.506 |
| Modifier score | 1.000 |
| Perplexity | 431.632 |